Nu Skin Enterprises Gestion

Gestion contrôle des critères 2/4

Le PDG Nu Skin Enterprises est Ryan Napierski, nommé en Mar2017, a un mandat de 7.67 ans. La rémunération annuelle totale est $ 5.84M, composée du salaire de 17% et des bonus 83%, y compris les actions et options de la société. détient directement 0.21% des actions de la société, d'une valeur de € 730.49K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 12.1 ans et 12.1 ans.

Informations clés

Ryan Napierski

Directeur général

US$5.8m

Rémunération totale

Pourcentage du salaire du PDG	17.0%
Durée du mandat du directeur général	7.7yrs
Propriété du PDG	0.2%
Durée moyenne d'occupation des postes de direction	12.1yrs
Durée moyenne du mandat des membres du conseil d'administration	12.1yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Ryan Napierski a-t-elle évolué par rapport aux bénéfices de Nu Skin Enterprises?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Sep 30 2024	n/a	n/a	-US$103m
Jun 30 2024	n/a	n/a	-US$148m
Mar 31 2024	n/a	n/a	-US$3m
Dec 31 2023	US$6m	US$992k	US$9m
Sep 30 2023	n/a	n/a	US$59m
Jun 30 2023	n/a	n/a	US$70m
Mar 31 2023	n/a	n/a	US$77m
Dec 31 2022	US$5m	US$942k	US$105m
Sep 30 2022	n/a	n/a	US$38m
Jun 30 2022	n/a	n/a	US$113m
Mar 31 2022	n/a	n/a	US$139m
Dec 31 2021	US$5m	US$801k	US$147m
Sep 30 2021	n/a	n/a	US$230m
Jun 30 2021	n/a	n/a	US$237m
Mar 31 2021	n/a	n/a	US$219m
Dec 31 2020	US$4m	US$721k	US$191m
Sep 30 2020	n/a	n/a	US$158m
Jun 30 2020	n/a	n/a	US$146m
Mar 31 2020	n/a	n/a	US$150m
Dec 31 2019	US$2m	US$688k	US$174m
Sep 30 2019	n/a	n/a	US$116m
Jun 30 2019	n/a	n/a	US$125m
Mar 31 2019	n/a	n/a	US$129m
Dec 31 2018	US$3m	US$621k	US$122m
Sep 30 2018	n/a	n/a	US$158m
Jun 30 2018	n/a	n/a	US$146m
Mar 31 2018	n/a	n/a	US$137m
Dec 31 2017	US$3m	US$594k	US$129m

Rémunération vs marché: La rémunération totale de Ryan ($USD 5.84M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché German ($USD 1.03M ).

Rémunération et revenus: La rémunération de Ryan a augmenté alors que l'entreprise n'est pas rentable.

PDG

Ryan Napierski (50 yo)

7.7yrs

Titularisation

US$5,838,579

Compensation

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Steven Lund	Co-Founder & Executive Chairman of the Board	28.8yrs	US$856.61k	0.24% € 835.7k
Ryan Napierski	President	7.7yrs	US$5.84m	0.21% € 730.5k
James Thomas	Executive VP	5.3yrs	US$1.86m	0.14% € 504.8k
Joseph Chang	Executive VP & Chief Scientific Officer	18.8yrs	US$1.12m	0.19% € 648.0k
Chayce Clark	Executive VP & General Counsel	3.3yrs	US$2.28m	0.32% € 1.1m
Steve Hatchett	Executive VP & Chief Product Officer	6.8yrs	US$1.41m	0.19% € 674.0k
Blake Roney	Founder	40.8yrs	US$621.69k	pas de données
Sandra Tillotson	Founder	28.8yrs	US$1.06m	pas de données
Joe Sueper	Senior VP & CTO	3.8yrs	pas de données	pas de données
Mark Adams	Chief Information Officer	18.8yrs	pas de données	pas de données
Scott Pond	Vice President of Investor Relations	no data	pas de données	pas de données
Ashok Pahwa	Chief Marketing Officer	16.5yrs	pas de données	pas de données

12.1yrs

Durée moyenne de l'emploi

66yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de NUS est chevronnée et expérimentée (12.1 années d'ancienneté moyenne).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Steven Lund	Co-Founder & Executive Chairman of the Board	28.8yrs	US$856.61k	0.24% € 835.7k
Ryan Napierski	President	3.4yrs	US$5.84m	0.21% € 730.5k
Edwina Woodbury	Independent Director	9.4yrs	US$273.20k	0.033% € 115.3k
Daniel Campbell	Lead Independent Director	27.7yrs	US$280.20k	0.21% € 741.0k
Lars Bohlin	Member of Anti-Aging Scientific Advisory Board	no data	pas de données	pas de données
Thomas Pisano	Independent Director	16.4yrs	US$257.08k	0.15% € 506.0k
Zoe Draelos	Member of the Anti-Aging Scientific Advisory Board	14.8yrs	pas de données	pas de données
Paul Cox	Member of Anti-Aging Scientific Advisory Board	no data	pas de données	pas de données
Tomas Prolla	Member of Anti-aging Scientific Advisory Board	15.1yrs	pas de données	pas de données
Zheqing Shen	Director	8.3yrs	US$249.20k	0.044% € 153.3k
Laura Nathanson	Independent Director	5.4yrs	US$268.20k	0.044% € 151.6k
Emma Battle	Independent Director	3.4yrs	US$264.33k	0.039% € 134.8k

12.1yrs

Durée moyenne de l'emploi

67.5yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la NUS est chevronné et expérimenté ( 12.1 années d'ancienneté moyenne).

Nu Skin Enterprises Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Insufficient new directors

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Chief Accounting Officer recently sold €110k worth of stock

Recent updates

Third quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on December 11, 2024

Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.74 loss in 3Q 2023)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 and Adjusts Earnings Guidance for the Year 2024

Nu Skin Introduces MYND360™, a New Line of Clinically Proven Supplements and Topicals for Mental Well-Being

Nu Skin Enterprises, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Upcoming dividend of US$0.06 per share

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Nu Skin Enterprises, Inc. Revises Financial Guidance for the Full Year of 2024

Nu Skin Enterprises, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Insufficient new directors

Upcoming dividend of US$0.06 per share

First quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024

First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.23 profit in 1Q 2023)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024

Now 21% undervalued after recent price drop

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 22%

Fourth quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Upcoming dividend of US$0.39 per share at 8.8% yield

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings released: US$0.74 loss per share (vs US$0.51 loss in 3Q 2022)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on December 6, 2023

Nu Skin Enterprises, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Insider selling

Upcoming dividend of US$0.39 per share at 6.4% yield

Nu Skin Enterprises, Inc. Provides Earnings Outlook for the Third Quarter and Full-Year 2023

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on September 6, 2023

Second quarter 2023 earnings released: EPS: US$0.54 (vs US$0.68 in 2Q 2022)

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from Russell 2000 Growth Index

Upcoming dividend of US$0.39 per share at 4.2% yield

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter and Full Year Ended March 31, 2023

First quarter 2023 earnings released: EPS: US$0.23 (vs US$0.77 in 1Q 2022)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 7, 2023

Chief Accounting Officer recently sold €110k worth of stock

Full year 2022 earnings released: EPS: US$2.10 (vs US$2.93 in FY 2021)

Nu Skin Enterprises, Inc. Announces Dividend Increase, Payable on March 8, 2023

Nu Skin Enterprises, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from S&P 400 Consumer Staples (Sector)

Nu Skin Enterprises Introduces the Next Generation of Smart Skincare with ageLOC LumiSpa iO

Upcoming dividend of US$0.39 per share

Third quarter 2022 earnings released: US$0.51 loss per share (vs US$0.99 profit in 3Q 2021)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Nu Skin Enterprises, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Chief Accounting Officer recently sold €63k worth of stock

Insider recently sold €254k worth of stock

Upcoming dividend of US$0.39 per share

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022

Second quarter 2022 earnings released: EPS: US$0.68 (vs US$1.18 in 2Q 2021)

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on September 7, 2022

Nu Skin Enterprises, Inc. Provides Revenue Guidance for the Second Quarter of 2022

Executive Chairman of the Board recently sold €955k worth of stock

Upcoming dividend of US$0.39 per share

First quarter 2022 earnings released: EPS: US$0.77 (vs US$0.94 in 1Q 2021)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 8, 2022

Nu Skin Enterprises, Inc. to Report Q1, 2022 Results on May 04, 2022